{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T17:15:26Z","timestamp":1782494126317,"version":"3.54.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T00:00:00Z","timestamp":1365120000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s00417-013-2333-4","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T06:19:01Z","timestamp":1365056341000},"page":"1717-1721","source":"Crossref","is-referenced-by-count":15,"title":["Topical tacrolimus for the management of acute allergic conjunctivitis in a mouse model"],"prefix":"10.1007","volume":"251","author":[{"given":"Irina S.","family":"Barequet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Platner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kobi","family":"Sade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Etkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Ziv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mordechai","family":"Rosner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohar","family":"Habot-Wilner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,5]]},"reference":[{"key":"2333_CR1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1056\/NEJM200101043440106","volume":"344","author":"AB Kay","year":"2001","unstructured":"Kay AB (2001) Allergy and allergic diseases. First of two parts. N Engl J Med 344:30\u201337","journal-title":"N Engl J Med"},{"key":"2333_CR2","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaci.2004.10.042","volume":"115","author":"SJ Ono","year":"2005","unstructured":"Ono SJ, Abelson MB (2005) Allergic conjunctivitis update on pathophysiology and prospects for future treatment. J Allergy Clin Immunol 115:118\u2013122","journal-title":"J Allergy Clin Immunol"},{"key":"2333_CR3","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s11882-012-0252-9","volume":"12","author":"O Kari","year":"2012","unstructured":"Kari O, Saari KM (2012) Diagnostics and new developments in the treatment of ocular allergies. Curr Allergy Asthma Rep 12:232\u2013239","journal-title":"Curr Allergy Asthma Rep"},{"key":"2333_CR4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1189\/jlb.0108058","volume":"85","author":"LA Spencer","year":"2009","unstructured":"Spencer LA, Szela CT, Perez SA, Kirchhoffer CL, Neves JS, Radke AL, Weller PF (2009) Human eosinophils constitutively express multiple TH1, Th2 and immunoregulatory cytokines that are secreted rapidly and differentially. J Leukoc Biol 85:117\u2013123","journal-title":"J Leukoc Biol"},{"key":"2333_CR5","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/ACI.0b013e3283303e2e","volume":"9","author":"I Offiah","year":"2009","unstructured":"Offiah I, Calder VL (2009) Immune mechanisms in allergic eye diseases: what is new? Curr Opin Allergy Clin Immunol 9:477\u2013481","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"2333_CR6","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/341758a0","volume":"341","author":"MW Harding","year":"1989","unstructured":"Harding MW, Galat A, Uehling DE, Schreiber SL (1989) A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature 341:758\u2013760","journal-title":"Nature"},{"key":"2333_CR7","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/341755a0","volume":"341","author":"JJ Siekierka","year":"1989","unstructured":"Siekierka JJ, Hung SH, Poe M, Lin CS, Sigal NH (1989) A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature 341:755\u2013777","journal-title":"Nature"},{"key":"2333_CR8","doi-asserted-by":"crossref","first-page":"22602","DOI":"10.1074\/jbc.270.38.22602","volume":"270","author":"VA Ruff","year":"1995","unstructured":"Ruff VA, Leach KL (1995) Direct demonstration of NFATp dephosphorylation and nuclear localization in activated HT-2 cells using a specific NFATp polyclonal antibody. J Biol Chem 270:22602\u201322607","journal-title":"J Biol Chem"},{"key":"2333_CR9","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1006\/bbrc.1994.1947","volume":"202","author":"K Tamura","year":"1994","unstructured":"Tamura K, Fujimura T, Iwasaki K, Sakuma S, Fujitsu T, Nakamura K, Shimomura K, Kuno T, Tanaka C, Kobayashi M (1994) Interaction of tacrolimus (FK506) and its metabolites with FKBP and calcineurin. Biochem Biophys Res Commun 202:437\u2013443","journal-title":"Biochem Biophys Res Commun"},{"key":"2333_CR10","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0092-8674(91)90124-H","volume":"66","author":"J Liu","year":"1991","unstructured":"Liu J, Farmer JD Jr, Lane WS, Friedman J, Weissman I, Schreiber SL (1991) Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66:807\u2013815","journal-title":"Cell"},{"key":"2333_CR11","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1001\/archderm.135.5.574","volume":"135","author":"T Ruzicka","year":"1999","unstructured":"Ruzicka T, Assmann T, Homey B (1999) Tacrolimus: the drug for the turn of the millennium? Arch Dermatol 135:574\u2013580","journal-title":"Arch Dermatol"},{"key":"2333_CR12","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jaci.2003.10.065","volume":"113","author":"P Vichyanond","year":"2004","unstructured":"Vichyanond P, Tantimongkolsuk C, Dumrongkigchaiporn P, Jirapongsananuruk O, Visitsunthorn N, Kosrirukvongs P (2004) Vernal keratoconjunctivitis: result of a novel therapy with 0.1 % topical ophthalmic FK-506 ointment. J Allergy Clin Immunol 113:355\u2013358","journal-title":"J Allergy Clin Immunol"},{"key":"2333_CR13","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/eye.2011.75","volume":"25","author":"A Kheirkhah","year":"2011","unstructured":"Kheirkhah A, Zavareh MK, Farzbod F, Mahbod M, Behrouz MJ (2011) Topical 0.005% tacrolimus eye drop for refractory vernal keratoconjunctivitis. Eye (Lond) 25:872\u2013880","journal-title":"Eye (Lond)"},{"key":"2333_CR14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1089\/jop.2009.0087","volume":"26","author":"Y Ohashi","year":"2010","unstructured":"Ohashi Y, Ebihara N, Fujishima H, Fukushima A, Kumagai N, Nakagawa Y, Namba K, Okamoto S, Shoji J, Takamura E, Hayashi K (2010) A randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1 % in severe allergic conjunctivitis. J Ocul Pharmacol Ther 26:165\u2013167","journal-title":"J Ocul Pharmacol Ther"},{"key":"2333_CR15","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/02713680802149115","volume":"33","author":"L Attas-Fox","year":"2008","unstructured":"Attas-Fox L, Barkana Y, Iskhakov V, Rayvich S, Gerber Y, Morad Y, Avni I, Zadok D (2008) Topical tacrolimus 0.03 % ointment for intractable allergic conjunctivitis: an open-label pilot study. Curr Eye Res 33:545\u2013549","journal-title":"Curr Eye Res"},{"key":"2333_CR16","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0002-9394(02)01982-7","volume":"135","author":"SM Rikkers","year":"2003","unstructured":"Rikkers SM, Holland GN, Drayton GE, Michel FK, Torres MF, Takahashi S (2003) Topical tacrolimus treatment of atopic eyelid disease. Am J Ophthalmol 135:297\u2013302","journal-title":"Am J Ophthalmol"},{"key":"2333_CR17","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/sj.eye.6702367","volume":"21","author":"E Nivenius","year":"2007","unstructured":"Nivenius E, van der Ploeg I, Jung K, Chryssanthou E, van Hage M, Montan PG (2007) Tacrolimus ointment vs steroid ointment for eyelid dermatitis in patients with atopic keratoconjunctivitis. Eye (Lond) 21:968\u2013975","journal-title":"Eye (Lond)"},{"key":"2333_CR18","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1468-3083.2008.02933.x","volume":"23","author":"H Zribi","year":"2009","unstructured":"Zribi H, Descamps V, Hoang-Xuan T, Crickx B, Doan S (2009) Dramatic improvement of atopic keratoconjunctivitis after topical treatment with tacrolimus ointment restricted to the eyelids. J Eur Acad Dermatol Venereol 23:489\u2013490","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2333_CR19","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1600-0420.2006.00699.x","volume":"84","author":"HM Virtanen","year":"2006","unstructured":"Virtanen HM, Reitamo S, Kari M, Kari O (2006) Effect of 0.03 % tacrolimus ointment on conjunctival cytology in patients with severe atopic blepharoconjunctivitis: a retrospective study. Acta Ophthalmol Scand 84:693\u2013695","journal-title":"Acta Ophthalmol Scand"},{"key":"2333_CR20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10384-004-0187-3","volume":"49","author":"J Shoji","year":"2005","unstructured":"Shoji J, Sakimoto T, Muromoto K, Inada N, Sawa M, Ra C (2005) Comparison of topical dexamethasone and topical FK506 treatment for the experimental allergic conjunctivitis model in BALB\/c mice. Jpn J Ophthalmol 49:205\u2013210","journal-title":"Jpn J Ophthalmol"},{"key":"2333_CR21","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/0091-6749(88)90020-6","volume":"82","author":"S Bonini","year":"1988","unstructured":"Bonini S, Bonini S, Vecchione A, Naim DM, Allansmith MR, Balsano F (1988) Inflammatory changes in conjunctival scrapings after allergen provocation in humans. J Allergy Clin Immunol 82:462\u2013469","journal-title":"J Allergy Clin Immunol"},{"issue":"708\u201310","key":"2333_CR22","first-page":"712","volume":"109","author":"R Mandal","year":"2011","unstructured":"Mandal R, Maiti P, Sasmal NK, Sinha N, Gupta A, Das KS, Biswas MC (2011) Ocular effects of long term use of topical steroids among children and adolescents with vernal keratoconjunctivitis: a prospective observational study. J Indian Med Assoc 109(708\u201310):712\u2013713","journal-title":"J Indian Med Assoc"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-013-2333-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-013-2333-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-013-2333-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:48:25Z","timestamp":1559072905000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-013-2333-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,5]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["2333"],"URL":"https:\/\/doi.org\/10.1007\/s00417-013-2333-4","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,5]]}}}